Shift Bioscience raises $16 M to advance cell simulation AI platform

Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing more effective drugs to treat age-related diseases.

Oramed and HTIT to form joint venture for oral drug products

The JV will commence a Phase III clinical trial of oral insulin in the US. Credit: Okrasiuk / Shutterstock.com Oramed Pharmaceuticals and Hefei Tianhui Biotech

August 3, 2023

SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): IPO SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price

September 19, 2023

Marinomed Biotech AG evaluates strategic options for Carragelose portfolio – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG evaluates strategic options for Carragelose portfolio 18.12.2023 / 08:33 CET/CEST The issuer

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.